BioCentury
ARTICLE | Financial News

Seidenberg, Harper launch Westlake with $320M inaugural fund

September 7, 2018 5:49 PM UTC

Kleiner Perkins’ Beth Seidenberg launched a life science investment firm, dubbed Westlake Village BioPartners, with $320 million in committed capital for its first fund. Sean Harper, EVP and head of R&D at Amgen Inc. (NASDAQ:AMGN), will join Westlake in January as co-managing director alongside Seidenberg, who remains a general partner at Kleiner Perkins.

Harper and Seidenberg have known each other for over 22 years, since first working together at Merck & Co. Inc. (NYSE:MRK)...